Payment overview · 2025
General Payments
$84.12
5 reported records · 3 companies
Healthcare provider profile · identity verified
David Joseph Johnson, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · OWENSBORO, KY · NPI 1215933247
Verified facts
What the public records show
CMS Open Payments records show David Joseph Johnson, M.D. received $84.12 in general payments during 2025 across 5 reported records.
PFIZER INC. accounted for 64.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Trelegy Ellipta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 209 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $53.82 | 64.0% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $16.62 | 19.8% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $13.68 | 16.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $84.12 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VELSIPITY Normalized: velsipity |
Drug | PFIZER INC. | $53.82 | 3 | 2025 |
Source payment records
|
|||||
| XELJANZ Normalized: xeljanz |
Drug | PFIZER INC. | $53.82 | 3 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $16.62 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $16.62 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $13.68 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $13.68 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 93 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
93 | 14 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
209 | 42 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 832 | 154 |
| Pantoprazole Sodium | Pantoprazole Sodium | 763 | 177 |
| Losartan Potassium | Losartan Potassium | 700 | 151 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 650 | 143 |
| Amlodipine Besylate | Amlodipine Besylate | 598 | 136 |
| Potassium Chloride | Potassium Chloride | 554 | 132 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 502 | 98 |
| Lisinopril | Lisinopril | 465 | 106 |
| Gabapentin | Gabapentin | 458 | 112 |
| Atorvastatin Calcium | Atorvastatin Calcium | 450 | 102 |
| Montelukast Sodium | Montelukast Sodium | 405 | 81 |
| Duloxetine Hcl | Duloxetine Hcl | 394 | 78 |
| Hydrochlorothiazide | Hydrochlorothiazide | 382 | 93 |
| Omeprazole | Omeprazole | 328 | 78 |
| Clonazepam | Clonazepam | 317 | 64 |
| Trazodone Hcl | Trazodone Hcl | 313 | 74 |
| Metformin Hcl | Metformin Hcl | 300 | 78 |
| Furosemide | Furosemide | 293 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 292 | 69 |
| Sertraline Hcl | Sertraline Hcl | 258 | 44 |
| Spironolactone | Spironolactone | 245 | 59 |
| Simvastatin | Simvastatin | 243 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 240 | 57 |
| Carvedilol | Carvedilol | 223 | 56 |
| Alprazolam | Alprazolam | 210 | 41 |
| Eliquis | Apixaban | 209 | 42 |
| Azithromycin | Azithromycin | 202 | 139 |
| Escitalopram Oxalate | Escitalopram Oxalate | 202 | 54 |
| Lovastatin | Lovastatin | 197 | 50 |
| Quetiapine Fumarate | Quetiapine Fumarate | 194 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 192 | 55 |
| Allopurinol | Allopurinol | 192 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 190 | 44 |
| Ezetimibe | Ezetimibe | 188 | 36 |
| Atenolol | Atenolol | 183 | 43 |
| Ozempic | Semaglutide | 174 | 38 |
| Tramadol Hcl | Tramadol Hcl | 173 | 50 |
| Synthroid | Levothyroxine Sodium | 169 | 35 |
| Methylprednisolone | Methylprednisolone | 165 | 131 |
| Meloxicam | Meloxicam | 162 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 162 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 159 | 44 |
| Prednisone | Prednisone | 159 | 64 |
| Donepezil Hcl | Donepezil Hcl | 150 | 22 |
| Alendronate Sodium | Alendronate Sodium | 146 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 42 |
| Citalopram Hbr | Citalopram Hydrobromide | 144 | 33 |
| Doxycycline Hyclate | Doxycycline Hyclate | 144 | 109 |
| Hydralazine Hcl | Hydralazine Hcl | 142 | 41 |
| Famotidine | Famotidine | 139 | 40 |
| Jardiance | Empagliflozin | 137 | 29 |
| Mirtazapine | Mirtazapine | 134 | 31 |
| Januvia | Sitagliptin Phosphate | 133 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 124 | 30 |
| Warfarin Sodium | Warfarin Sodium | 123 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 112 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 111 | 24 |
| Ropinirole Hcl | Ropinirole Hcl | 111 | 21 |
| Raloxifene Hcl | Raloxifene Hcl | 106 | 26 |
| Sucralfate | Sucralfate | 103 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 100 | 18 |
| Glipizide | Glipizide | 99 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 98 | 26 |
| Memantine Hcl | Memantine Hcl | 98 | 16 |
| Estradiol | Estradiol | 93 | 25 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 93 | 14 |
| Ondansetron Odt | Ondansetron | 91 | 41 |
| Fluconazole | Fluconazole | 90 | 47 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 88 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 80 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 80 | 52 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 79 | 18 |
| Diazepam | Diazepam | 72 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 71 | 36 |
| Klor-Con M20 | Potassium Chloride | 70 | 25 |
| Risperidone | Risperidone | 69 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 15 |
| Xarelto | Rivaroxaban | 67 | 11 |
| Colestipol Hcl | Colestipol Hcl | 66 | 20 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 66 | 19 |
| Bupropion Xl | Bupropion Hcl | 65 | 14 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 65 | suppressed |
| Lorazepam | Lorazepam | 65 | 21 |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 64 | 53 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 64 | 15 |
| Myrbetriq | Mirabegron | 62 | 11 |
| Temazepam | Temazepam | 60 | 11 |
| Buspirone Hcl | Buspirone Hcl | 59 | 12 |
| Azelastine Hcl | Azelastine Hcl | 52 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | 12 |
| Fenofibrate | Fenofibrate | 50 | 11 |
| Trulicity | Dulaglutide | 50 | 15 |
| Valacyclovir | Valacyclovir Hcl | 49 | 15 |
| Farxiga | Dapagliflozin Propanediol | 47 | 14 |
| Modafinil | Modafinil | 47 | suppressed |
| Scopolamine | Scopolamine | 47 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 41 |
| Meclizine Hcl | Meclizine Hcl | 46 | 21 |
| Celecoxib | Celecoxib | 45 | 15 |
| Topiramate | Topiramate | 45 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 44 | suppressed |
| Mounjaro | Tirzepatide | 43 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 43 | suppressed |
| Linzess | Linaclotide | 42 | 13 |
| Repatha Sureclick | Evolocumab | 42 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 15 |
| Nitroglycerin | Nitroglycerin | 40 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 37 |
| Amoxicillin | Amoxicillin | 39 | 27 |
| Digoxin | Digoxin | 37 | suppressed |
| Pregabalin | Pregabalin | 37 | suppressed |
| Aripiprazole | Aripiprazole | 36 | 14 |
| Irbesartan | Irbesartan | 36 | suppressed |
| Valsartan | Valsartan | 36 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 35 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 33 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 33 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 32 | suppressed |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 31 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 31 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 29 | 11 |
| Lubiprostone | Lubiprostone | 29 | suppressed |
| Fentanyl | Fentanyl | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 28 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Eszopiclone | Eszopiclone | 27 | suppressed |
| Glipizide Er | Glipizide | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Trimethoprim | Trimethoprim | 27 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 26 | 19 |
| Baclofen | Baclofen | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Nateglinide | Nateglinide | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Metolazone | Metolazone | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 24 | suppressed |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Gemtesa | Vibegron | 23 | suppressed |
| Nystatin | Nystatin | 23 | 16 |
| Fluocinonide | Fluocinonide | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 17 |
| Carbamazepine | Carbamazepine | 20 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Methadone Hcl | Methadone Hcl | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Lactulose | Lactulose | 19 | 13 |
| Bumetanide | Bumetanide | 18 | suppressed |
| Finasteride | Finasteride | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 12 |
| Ramipril | Ramipril | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Constulose | Lactulose | 12 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Etodolac | Etodolac | 12 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Testosterone | Testosterone | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Xtampza Er | Oxycodone Myristate | 12 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Savella | Milnacipran Hcl | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $84.12 · 5 records | PFIZER INC. | AREXVY, EVENITY, PROLIA, TRELEGY ELLIPTA, VELSIPITY, XELJANZ | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error